Search Results - "Boyd, Mellonie"

Postischemic administration of adenosine amine congener (ADAC): analysis of recovery in gerbils by Von Lubitz, Dag K.J.E., Lin, Rick C.-S., Paul, Ian A., Beenhakker, Mark, Boyd, Mellonie, Bischofberger, Norbert, Jacobson, Kenneth A.

“…Although adenosine receptor-based treatment of cerebral ischemia and other neurodegenerative disorders has been frequently advocated, cardiovascular side…”
Get full text

Properties of phagocyte NADPH oxidase p47-phox mutants with unmasked SH3 (Src homology 3) domains: full reconstitution of oxidase activity in a semi-recombinant cell-free system lacking arachidonic acid by Peng, Guihong, Huang, Jin, Boyd, Mellonie, Kleinberg, Michael E

“…In an early step in the assembly of the phagocyte NADPH oxidase, p47-phox translocates from the cytosol to the membrane, mediated by engagement of the…”
Get full text

Chronic administration of adenosine A3 receptor agonist and cerebral ischemia : neuronal and glial effects by VON LUBITZ, D. K. J. E, LIN, R. C.-S, BOYD, M, BISCHOFBERGER, N, JACOBSON, K. A

“…We have previously shown that chronic administration of the selective A3 receptor agonist N6-(3-iodobenzyl)-5'-N-methylcarboxoamidoadenosine (IB-MECA) leads to…”
Get full text

Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist by VON LUBITZ, D. K. J. E, LIN, R. C.-S, BISCHOFBERGER, N, BEENHAKKER, M, BOYD, M, LIPARTOWSKA, R, JACOBSON, K. A

“…Although the selectivity and potency of adenosine amine congener (ADAC) at adenosine A1 receptors are similar to other highly selective agonists at this…”
Get full text

Chronic administration of adenosine A 3 receptor agonist and cerebral ischemia: neuronal and glial effects by Von Lubitz, Dag K.J.E., Lin, Rick C.-S., Boyd, Mellonie, Norbert Bischofberger, Jacobson, Kenneth A.

“…We have previously shown that chronic administration of the selective A 3 receptor agonist N 6-(3-iodobenzyl)-5′- N-methylcarboxoamidoadenosine (IB-MECA) leads…”
Get full text

Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A 1 receptor agonist by Von Lubitz, Dag K.J.E, Lin, Rick C.-S, Bischofberger, Norbert, Beenhakker, Mark, Boyd, Mellonie, Lipartowska, Renata, Jacobson, Kenneth A

“…Although the selectivity and potency of adenosine amine congener (ADAC) at adenosine A 1 receptors are similar to other highly selective agonists at this…”
Get full text